DK164056C - Analogifremgangsmaade til fremstilling af thiazol-derivater - Google Patents

Analogifremgangsmaade til fremstilling af thiazol-derivater

Info

Publication number
DK164056C
DK164056C DK435181A DK435181A DK164056C DK 164056 C DK164056 C DK 164056C DK 435181 A DK435181 A DK 435181A DK 435181 A DK435181 A DK 435181A DK 164056 C DK164056 C DK 164056C
Authority
DK
Denmark
Prior art keywords
preparation
analogy procedure
thiazol derivatives
thiazol
derivatives
Prior art date
Application number
DK435181A
Other languages
Danish (da)
English (en)
Other versions
DK164056B (da
DK435181A (da
Inventor
Richard Paul Pioch
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22712591&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK164056(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK435181A publication Critical patent/DK435181A/da
Publication of DK164056B publication Critical patent/DK164056B/da
Application granted granted Critical
Publication of DK164056C publication Critical patent/DK164056C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
DK435181A 1980-10-02 1981-10-01 Analogifremgangsmaade til fremstilling af thiazol-derivater DK164056C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/193,192 US4375547A (en) 1980-10-02 1980-10-02 N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine
US19319280 1980-10-02

Publications (3)

Publication Number Publication Date
DK435181A DK435181A (da) 1982-05-12
DK164056B DK164056B (da) 1992-05-04
DK164056C true DK164056C (da) 1992-09-28

Family

ID=22712591

Family Applications (2)

Application Number Title Priority Date Filing Date
DK435181A DK164056C (da) 1980-10-02 1981-10-01 Analogifremgangsmaade til fremstilling af thiazol-derivater
DK012391A DK167759B1 (da) 1980-10-02 1991-01-24 Thiazol-derivater til anvendelse som mellemprodukter

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK012391A DK167759B1 (da) 1980-10-02 1991-01-24 Thiazol-derivater til anvendelse som mellemprodukter

Country Status (36)

Country Link
US (1) US4375547A (es)
EP (1) EP0049618B1 (es)
JP (1) JPS5791980A (es)
KR (1) KR850001795B1 (es)
AR (1) AR241439A1 (es)
AU (1) AU542553B2 (es)
BG (1) BG60249B2 (es)
CA (1) CA1166248A (es)
CS (1) CS227015B2 (es)
CY (1) CY1351A (es)
DD (1) DD200371A5 (es)
DE (1) DE3171819D1 (es)
DK (2) DK164056C (es)
EG (1) EG15678A (es)
ES (2) ES8301950A1 (es)
FI (2) FI813058L (es)
GB (1) GB2084581B (es)
GR (1) GR75023B (es)
HK (1) HK15987A (es)
HU (1) HU188697B (es)
IE (1) IE51603B1 (es)
IL (1) IL63980A (es)
LU (1) LU88293I2 (es)
MX (1) MX5723A (es)
MY (1) MY8700247A (es)
NL (1) NL930107I2 (es)
NO (1) NO155885C (es)
NZ (1) NZ198523A (es)
PH (1) PH18135A (es)
PL (2) PL130526B1 (es)
PT (1) PT73757B (es)
RO (2) RO85815B (es)
SU (1) SU1184443A3 (es)
UA (1) UA6081A1 (es)
YU (1) YU42728B (es)
ZA (1) ZA816817B (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904792A (en) * 1980-10-02 1990-02-27 Eli Lilly And Company N-thiazolymethylthioalkyl-N'-alkylamidines and related compounds
NZ202797A (en) * 1981-12-28 1985-08-30 Lilly Co Eli Pyrimidine derivatives and pharmaceutical compositions
US4474794A (en) * 1982-03-19 1984-10-02 Eli Lilly And Company N-Thiazolylmethylthioalkyl-N1 -alkenyl (or alkynyl)guanidines and related compounds
FR2531703A1 (fr) * 1982-08-13 1984-02-17 Sanofi Sa 2-aza-5-thiahexan-1-ones 1,6-disubstituees, leurs sels, procede pour leur preparation et compositions pharmaceutiques les renfermant
US4587344A (en) * 1983-02-07 1986-05-06 Eli Lilly And Company Isothiourea synthesis process
BG45216A3 (es) * 1983-02-07 1989-04-14 Lilly And Co, Eli,Us
US4468517A (en) * 1983-05-12 1984-08-28 Eli Lilly And Company Synthesis of thiazoles
DE3417127A1 (de) * 1984-05-09 1985-11-14 Papst-Motoren GmbH & Co KG, 7742 St Georgen Kleinstventilator
DE3531504A1 (de) * 1985-09-04 1987-03-12 Basf Ag 3-aminomethylpyrrol-1-yl-alkylamine und diese verbindungen enthaltende therapeutische mittel
IL80961A0 (en) * 1985-12-18 1987-03-31 Lilly Co Eli Synthesis of nizatidine
US4777260A (en) * 1985-12-18 1988-10-11 Eli Lilly And Company Synthesis of nizatidine intermediate
ES2053462T3 (es) 1987-04-06 1994-08-01 Heumann Pharma Gmbh & Co Procedimiento para la produccion de derivados de nitroetano.
ES2007959A6 (es) * 1988-07-11 1989-07-01 Vinas Lab Procedimiento para la obtencion de derivados tiazolicos.
ES2151480T3 (es) * 1991-05-21 2001-01-01 Lilly Co Eli Procedimiento para preparar productos intermedios de nizatidina y compuestos relacionados.
ES2038922B1 (es) * 1991-12-30 1994-04-16 Fermentaciones Y Sintesis Espa Procedimiento para la obtencion de nizatidina.
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
DE69307310D1 (de) * 1992-05-12 1997-02-20 Zeria Pharm Co Ltd Neue quaternäre ammoniumsalze und deren medizinische verwendung
US5541335A (en) * 1994-07-11 1996-07-30 Torcan Chemical Ltd. Process for preparing nizatidine
US5470865A (en) * 1994-08-30 1995-11-28 Eli Lilly And Company Pharmaceutical composition
SK23199A3 (en) * 1996-09-11 1999-08-06 Knoll Ag Process for the preparation of nizatidine
IT1299198B1 (it) 1998-03-05 2000-02-29 Nicox Sa Sali nitrati di farmaci antiulcera
AU772188B2 (en) 1998-11-17 2004-04-08 Nitromed, Inc. Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
US20080044481A1 (en) * 2004-05-27 2008-02-21 Mordechai Harel Microparticles for Oral Delivery
WO2006071659A1 (en) * 2004-12-29 2006-07-06 Trustees Of Boston University Delivery of h2 antagonists
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
US20090275622A1 (en) * 2008-04-30 2009-11-05 Prasoona Linga Nizatidine formulations
EP2825159B1 (en) 2012-03-15 2022-06-22 Boehringer Ingelheim Vetmedica GmbH Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
KR102455648B1 (ko) 2013-07-19 2022-10-19 베링거잉겔하임베트메디카게엠베하 보존된 에테르화된 사이클로덱스트린 유도체 함유 액체 수성 약제학적 조성물
BR112016011111B1 (pt) 2013-12-04 2022-11-16 Boehringer Ingelheim Vetmedica Gmbh Composições farmacêuticas aprimoradas de pimobendan
WO2015155297A1 (en) 2014-04-11 2015-10-15 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical combinations of dabigatran and h2-receptor antagonists
EP2942058A1 (en) 2014-05-09 2015-11-11 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of rivaroxaban and H2-receptor antagonists
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
US3917593A (en) * 1972-05-22 1975-11-04 Smithkline Corp N-alkenyl and N-alkynyl (2-quinolyl)thio-acetamides
US3853865A (en) * 1972-06-26 1974-12-10 Smithkline Corp N-aminomethyl-2-amino(and 2-amino-methyl)-2-heterocyclic-thioacetamides
GB1421792A (en) * 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
US4191769A (en) * 1974-03-12 1980-03-04 Smith Kline & French Laboratories Limited Isothiourea compounds and pharmacological use
US4061637A (en) * 1974-05-14 1977-12-06 Istituto Luso Farmaco D'italia S.R.L. Certain 4-aryl-5-(4-phenylpiperazino)alkyl-4-thiazolin-2-ones
US4173644A (en) * 1975-02-03 1979-11-06 Smith Kline & French Laboratories Limited Thiourea compounds, compositions and methods and use
US4166856A (en) * 1975-05-21 1979-09-04 Smith Kline & French Laboratories Limited Thiazole and isothiazole derivative as blockers of histamine H2 -receptors
GB1574214A (en) * 1976-03-11 1980-09-03 Smith Kline French Lab Amidines
GB1602458A (en) * 1977-05-05 1981-11-11 Smith Kline French Lab Bisamidines as histamine h2-antagonists
JPS5444660A (en) * 1977-08-29 1979-04-09 Yamanouchi Pharmaceut Co Ltd Heterocyclic compound and its preparation
DE2835695A1 (de) * 1977-08-29 1979-03-15 Yamanouchi Pharma Co Ltd Neue heterocyclische verbindungen, verfahren zu ihrer herstellung und arzneimittel, die diese enthalten
US4210658A (en) * 1977-09-08 1980-07-01 Smith Kline & French Laboratories Limited Amidinosulphonic acid derivatives
DE2905134A1 (de) * 1978-02-17 1979-08-23 Degussa Neue acylierte aminoalkyl-cyanoguanidine mit einem heterocyclischen rest
ATE1353T1 (de) * 1978-05-24 1982-08-15 Imperial Chemical Industries Plc Anti-sekretion thiadiazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
US4200578A (en) * 1978-12-18 1980-04-29 Bristol-Myers Company Thiazole derivatives

Also Published As

Publication number Publication date
DK164056B (da) 1992-05-04
NO155885B (no) 1987-03-09
FI813058L (fi) 1982-04-03
GB2084581A (en) 1982-04-15
NO813334L (no) 1982-04-05
CS227015B2 (en) 1984-04-16
CY1351A (en) 1987-04-24
YU42728B (en) 1988-12-31
PH18135A (en) 1985-04-03
MY8700247A (en) 1987-12-31
NZ198523A (en) 1985-12-13
AR241439A1 (es) 1992-07-31
EG15678A (en) 1986-12-30
NL930107I1 (nl) 1993-10-18
ES514868A0 (es) 1983-05-01
IE51603B1 (en) 1987-01-21
CA1166248A (en) 1984-04-24
DE3171819D1 (en) 1985-09-19
BG60249B1 (bg) 1994-03-24
KR850001795B1 (ko) 1985-12-21
NO155885C (no) 1987-06-17
IL63980A0 (en) 1982-01-31
JPH021141B2 (es) 1990-01-10
BG60249B2 (en) 1994-03-24
MX5723A (es) 1993-12-01
KR830007602A (ko) 1983-11-04
DD200371A5 (de) 1983-04-20
RO85815B (ro) 1984-11-30
ES505950A0 (es) 1983-01-01
ES8306135A1 (es) 1983-05-01
HK15987A (en) 1987-02-27
ES8301950A1 (es) 1983-01-01
GB2084581B (en) 1985-02-27
GR75023B (es) 1984-07-12
DK12391D0 (da) 1991-01-24
PL233295A1 (es) 1982-12-20
RO82215A (ro) 1983-07-07
RO85815A (ro) 1984-11-25
AU542553B2 (en) 1985-02-28
PL130626B1 (en) 1984-08-31
PT73757B (en) 1983-01-13
DK167759B1 (da) 1993-12-13
SU1184443A3 (ru) 1985-10-07
DK435181A (da) 1982-05-12
FI76570B (fi) 1988-07-29
FI76570C (fi) 1988-11-10
ZA816817B (en) 1983-05-25
LU88293I2 (fr) 1994-05-04
UA6081A1 (uk) 1994-12-29
JPS5791980A (en) 1982-06-08
PT73757A (en) 1981-11-01
IL63980A (en) 1986-04-29
NL930107I2 (nl) 1997-02-03
PL238035A1 (en) 1983-02-28
HU188697B (en) 1986-05-28
PL130526B1 (en) 1984-08-31
EP0049618A1 (en) 1982-04-14
YU236481A (en) 1983-10-31
AU7594581A (en) 1982-04-08
DK12391A (da) 1991-01-24
EP0049618B1 (en) 1985-08-14
IE812285L (en) 1982-04-02
RO82215B (ro) 1983-06-30
US4375547A (en) 1983-03-01

Similar Documents

Publication Publication Date Title
DK164056C (da) Analogifremgangsmaade til fremstilling af thiazol-derivater
DK157876C (da) Analogifremgangsmaade til fremstilling af imidazo-rifamycin-derivater
DK155282C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater
DK157680C (da) Analogifremgangsmaade til fremstilling af indolderivater
DK534481A (da) Fremgangsmaade til fremstilling af 1-sulfo-2-oxoazetidinderivater
DK2281A (da) Fremgangsmaade til fremstilling af tiazolinderivater
DK163243C (da) Fremgangsmaade til fremstilling af cephalosporinderivater
DK300981A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK162524C (da) Analogifremgangsmaade til fremstilling af 5-alkylthio-tetrazolderivater
DK161581A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK157920C (da) Analogifremgangsmaade til fremstilling af indolderivater
DK150903C (da) Analogifremgangsmaade til fremstilling af benzisoselenazoloner
DK157995C (da) Analogifremgangsmaade til fremstilling af indolderivater
DK100281A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK153788C (da) Analogifremgangsmaade til fremstilling af 2-substituerede benzofuranderivater
DK162167C (da) Analogifremgangsmaade til fremstilling af mitosanderivater
DK152363C (da) Analogifremgangsmaade til fremstilling af 3-(omega-piperazinylalkyl)-alkylendioxybenzenderivater
DK564781A (da) Fremgangsmaade til fremstilling af pyrazoloindazolderivater
DK151256C (da) Analogifremgangsmaade til fremstilling af alkylendioxybenzenderivater
DK172181A (da) Fremgangsmaade til fremstilling af 9-carbamoyl-9-aminoalkylfluoren-derivater
DK151956C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater
DK565281A (da) Fremgangsmaade til fremstilling af quinolon-derivater
DK85281A (da) Fremgangsmaade til fremstilling af phenoxyderivater
DK448981A (da) Fremgangsmaade til fremstilling af 4-chinolinmethanderivater
DK424781A (da) Fremgangsmaade til fremstilling af quinolonderivater

Legal Events

Date Code Title Description
PUP Patent expired